Breaking NewsUK Cannabis Firm GW Pharmaceuticals Honoured By Her Majesty...

UK Cannabis Firm GW Pharmaceuticals Honoured By Her Majesty For Its Innovation


LEADING UK cannabis company GW Pharmaceuticals has received the Queen’s Award for Enterprise 2021 in recognition of its ground-breaking work in creating the world’s first regulatory approved, prescription cannabis-based medicines.

Regarded as the highest official UK award for British business, the Queen’s Award for Enterprise is an annual award which recognises outstanding achievement in Innovation and is now in its 55th year. 

Formed in 1998, GW has successfully navigated significant barriers to enable the development, manufacture and commercialisation of regulatory approved cannabis-based medicines such a Sativex and Epidiolex, supporting tens of thousands of patients and families around the world. 

Supporting Patients

Most of its 1,100 staff are employed in the UK and over the years has invested over £1.3bn in the research, development and infrastructure needed to bring innovative medicines to patients. 

Dr Geoffrey Guy, Founder and Chairman said: “We are honoured to receive such a prestigious award for British businesses. When Dr Brian Whittle and I founded GW 23 years ago, our mission was to improve the lives of seriously ill patients by unlocking the potential of the cannabis plant through rigorous scientific investigations and extensive clinical trials in order to obtain regulatory approval for such medicines to benefit patients. 

“Today, I want to thank every employee, clinician, researcher, patient and caregiver for helping advance and achieve that mission.”

Earlier this year Irish firm Jazz Pharmaceuticals had a $7.2bn takeover bid for NASDAQ-listed GW accepted.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.



Please enter your comment!
Please enter your name here

Latest news

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover...

Columbia Care Platinum Joins Forces With Poppy Jamie

Leading organic, vegan and regeneratively-farmed, plant-based CBD brand, Columbia Care Platinum(, announces it has teamed up with Poppy Jamie, mental wellbeing...

InterCure Announces European Expansion with International Cannabis Brand Cookies

InterCure Ltd. today announced its international expansion into Europe through a partnership with iconic cannabis brand Cookies. The parties entered...

Groups From 56 Countries Ask UN To Ensure Secretive ‘Cannabis Initiative’ Is Open To Public Scrutiny

ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy...

The New Common Agricultural Policy Has Been Adopted And the Maximum THC Level on the Field Has Been Restored to 0.3%

It was in October 2020 when we announced that the European Parliament had voted in favour of restoring the...

European Medical Cannabis Tech Accelerator Opens Call for Submissions

The first and only hybrid tech accelerator in Europe dedicated to the medical cannabis industry offers €100,000 grant to early-stage startups from around the world.

Must read

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior...

You might also likeRELATED
Recommended to you